FIGURE

Figure 6

ID

ZDB-FIG-210414-32

Publication

Banerji et al., 2021 - Enhancing glucose metabolism via gluconeogenesis is therapeutic in a zebrafish model of Dravet syndrome

Other Figures

All Figure Page

Back to All Figure Page

Figure 6

PK11195 treatment effectively suppresses electrographic seizure activity. (A) Representative 10-min local field LFP recording epochs with 6-dpf scn1lab mutants treated with control media and 10 μM PK11195 for 3-h. (B) The graph shows a significant reduction in the frequency of ictal- and inter-ictal-like electrographic seizure events with a 3-h 10 μM PK11195 exposure. (C) The graph shows a significant effect of 3-h 10 μM PK11195 exposure in significantly suppressing ictal events alone. (D) No change in ictal event duration was observed among the two groups. All drug-treated scn1lab mutant larvae were freed from agar post-experiment and the survival rate at 24-h was 94%. Data represent 6 dpf from three independent clutches, n = 17 for controls; n = 22 for PK11195 treatment. Data are presented as mean ± SEM; Student’s unpaired t-test was used. Asterisks (*) indicate a significance *P < 0.05; **P < 0.001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Brain Commun